Beximco Pharma BXP Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
UK
LSE
Beximco Pharma (BXP)
Beximco Pharma (BXP) Financials

Beximco Pharma (BXP)

33.50

0.00

(0.00%)

Closed November 26 10:30AM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End June 29 2023	2016	2017	2018	2019	2020	2021	2022	2023
	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)
Total Revenue	20.03B	15.51B	17.72B	22.82B	25.61B	29.49B	34.67B	39.27B
Operating Income	4.46B	3.45B	4.03B	5.04B	5.99B	7.09B	6.9B	7.22B
Pre Tax Income	3.66B	2.89B	3.36B	3.95B	4.65B	6.38B	6.69B	6.07B
Net Income	2.95B	2.23B	2.54B	3.03B	3.51B	5.13B	5.12B	4.61B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	763.3	509.7	580.6	694.4	804.6	1149.4	1073.1	966.5
EBIT	4.29B	3.31B	3.89B	4.96B	6.01B	7.68B	7.63B	7.28B
EBITDA	5.6B	4.23B	4.87B	5.98B	7.1B	8.21B	8.57B	9.36B

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions